ANDERMAN TODD (Chief Legal Officer) received a stock award from OCULAR THERAPEUTIX, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2026ACC: 0001104659-26-001296
Officer· Chief Legal Officer
Since Oct 2024
+262.55K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
262.55K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+64.90K
Price / share
—
Trade value
—
% of position
74.1%
1/2/2026
87.57K→152.47K
Total
Net shares
+64.90K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +64.90K | — | — | 74.1% | 87.57K | 152.47K |
| Total | +64.90K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
197.65K shares
Shares
+197.65K
Strike price
11.82
Held after
197.65K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock197.65K shares | 1/2/2026 | A · Award | +197.65K | 11.82 | — | 197.65K |